SULLIVAN AMY (Chief Financial Officer) purchased 13.8% of their position (10.25K shares) of IO BIOTECH, INC. on the open market
Open‑market purchase worth $8.5K — a moderate purchase. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 12/23/2024ACC: 0000905148-24-003410
Officer· Chief Financial Officer
Since Oct 2022
+10.25K
Net shares
Net buyer
$8.5K
Total acquired
1
Open market trades
1B · 0S
1
Total transactions
10.25K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+10.25K
Price / share
$0.83
Trade value
$8.48K
% of position
13.8%
12/23/2024
74.38K→84.63K
Total
Net shares
+10.25K
Net value
$8.48K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 12/23/2024 | P · Purchase | +10.25K | $0.83 | $8.48K | 13.8% | 74.38K | 84.63K |
| Total | +10.25K | $8.48K | ||||||
Derivative Transactions0
No derivative transactions reported